Simplex Trading
EIGR

Simplex Trading’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Simplex Trading’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-80
Closed -$2K – 10241
2023
Q1 		$2K Buy
80
+20
+33% +$930 ﹤0.01% 8581
2022
Q4 		$2K Sell
60
-80
-57% -$9.61K ﹤0.01% 8702
2022
Q3 		$31K Buy
140
+133
+1,900% +$32.7K ﹤0.01% 7050
2022
Q2 		$1K Sell
7
-173
-96% -$34.9K ﹤0.01% 9741
2022
Q1 		$44K Buy
+180
New +$28.4K ﹤0.01% 7326
2021
Q4 		– Sell
-483
Closed -$126K – 11699
2021
Q3 		$126K Hold
483
– – ﹤0.01% 6292
2021
Q2 		$123K Buy
483
+481
+24,050% +$120K ﹤0.01% 6438
2021
Q1 		$55K Buy
+2
New +$630 ﹤0.01% 6503
2020
Q4 		– Hold
0
– – – 7376
2020
Q3 		– Hold
0
– – – 6924
2016
Q1 		– Hold
0
– -$7K – 6414
2015
Q4 		– Hold
0
– – – 3660
2015
Q3 		– Sell
-1
Closed -$530 – 2665
2015
Q2 		$201K Hold
1
– – 0.02% 794
2015
Q1 		$148K Buy
+1
New +$8.74K 0.02% 860

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Simplex Trading's EIGR Position: Q1 2024 in Review

Simplex Trading sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 437 shares — an estimated $2K sold.

Simplex Trading first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $532K in Q1 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Simplex Trading reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 437 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $2K.
  • Simplex Trading first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 13 quarters.
  • Simplex Trading's Eiger BioPharmaceuticals, Inc. position peaked at $532K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.